Dendritic cell vaccine induces antigen-specific CD8⁺ T cells that are metabolically distinct from those of peptide vaccine and is well-combined with PD-1 checkpoint blockade

Koji NagaokaDepartment of Immunotherapeutics, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan;Medinet Co. Ltd., Kohoku-Ku, Yokohama, Japan

Akihiro HosoiDepartment of Immunotherapeutics, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan;Medinet Co. Ltd., Kohoku-Ku, Yokohama, Japan

Tamaki IinoDepartment of Immunotherapeutics, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan;Medinet Co. Ltd., Kohoku-Ku, Yokohama, Japan

Yasuyuki MorishitaDepartment of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Bunkyo-Ku, Tokyo, Japan

Hirokazu MatsushitaDepartment of Immunotherapeutics, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan

Kazuhiro KakimiDepartment of Immunotherapeutics, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, JapanCorrespondence[email protected]

Your download is now in progress and you may close this window